
Introduction: On March 30, 2026, the Saudi Standards, Metrology and Quality Organization (SASO) implemented the new SASO IEC 60601-1-2:2026 standard, mandating comprehensive RF immunity testing for medical electrical equipment, including multi-parameter monitors and infusion pumps. This development particularly affects Chinese exporters, potentially delaying deliveries by 6–8 weeks during critical procurement periods for Middle Eastern hospitals.

The SASO IEC 60601-1-2:2026 standard requires all medical electrical devices sold in Saudi Arabia to undergo full RF field-induced conducted disturbance immunity (RFI) testing. This applies specifically to equipment such as multi-parameter patient monitors, smart infusion pumps, and portable ultrasound devices. The implementation date was March 30, 2026, with no transitional period announced.
Chinese manufacturers of patient monitoring systems and infusion pumps face immediate testing bottlenecks. The RFI full-item testing requires specialized facilities, with current capacity constraints adding 6–8 weeks to certification timelines.
Freight forwarders specializing in medical equipment shipments to GCC countries must adjust scheduling. The testing delays are coinciding with Q2 hospital procurement cycles, potentially causing missed delivery windows.
Accredited laboratories are experiencing surge demand for RFI testing slots. Priority access is going to established suppliers with existing SASO certification histories.
Manufacturers should immediately audit their product portfolios to prioritize testing for high-volume export models. Early engagement with SASO-accredited labs is critical given limited testing capacity.
Exporters need to review component sourcing strategies. Some RF-sensitive components may require redesign or replacement to meet the new immunity thresholds.
Technical documentation teams must update risk management files and test reports to include the new RFI protocols. Historical test data may require revalidation under the updated methodology.
From an industry standpoint, this represents Saudi Arabia's alignment with the most recent IEC 60601-1-2 amendments. While challenging in the short term, the move standardizes requirements across GCC markets. Manufacturers with existing EU MDR or FDA submissions may find adaptation easier, as the SASO requirements now mirror contemporary EMC frameworks.
The standard's immediate implementation without transition suggests Saudi regulators are prioritizing electromagnetic safety in clinical environments. This may signal future expansions of testing requirements to additional device categories.
The SASO update creates immediate compliance challenges but establishes clearer long-term standards for medical device EMC in the region. Exporters should treat this as both an operational hurdle and an opportunity to future-proof their Saudi market access capabilities. Proactive engagement with testing bodies and early technical reviews will be crucial through 2026.
• Saudi Standards, Metrology and Quality Organization (SASO) official release
• Industry reports on medical device export timelines
• Testing laboratory capacity assessments (Q1 2026)
Related Intelligence
The Morning Broadsheet
Daily chemical briefings, market shifts, and peer-reviewed summaries delivered to your terminal.